These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. The neural chaperone proSAAS blocks α-synuclein fibrillation and neurotoxicity. Jarvela TS; Lam HA; Helwig M; Lorenzen N; Otzen DE; McLean PJ; Maidment NT; Lindberg I Proc Natl Acad Sci U S A; 2016 Aug; 113(32):E4708-15. PubMed ID: 27457957 [TBL] [Abstract][Full Text] [Related]
14. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations. Sahay S; Ghosh D; Singh PK; Maji SK Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727 [TBL] [Abstract][Full Text] [Related]
15. The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells. Fares MB; Ait-Bouziad N; Dikiy I; Mbefo MK; Jovičić A; Kiely A; Holton JL; Lee SJ; Gitler AD; Eliezer D; Lashuel HA Hum Mol Genet; 2014 Sep; 23(17):4491-509. PubMed ID: 24728187 [TBL] [Abstract][Full Text] [Related]
16. Zonisamide attenuates α-synuclein neurotoxicity by an aggregation-independent mechanism in a rat model of familial Parkinson's disease. Arawaka S; Fukushima S; Sato H; Sasaki A; Koga K; Koyama S; Kato T PLoS One; 2014; 9(2):e89076. PubMed ID: 24586512 [TBL] [Abstract][Full Text] [Related]
17. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. Li J; Uversky VN; Fink AL Biochemistry; 2001 Sep; 40(38):11604-13. PubMed ID: 11560511 [TBL] [Abstract][Full Text] [Related]
18. The Role of α-Synuclein in Methamphetamine-Induced Neurotoxicity. Wu M; Su H; Zhao M Neurotox Res; 2021 Jun; 39(3):1007-1021. PubMed ID: 33555547 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional mutagenesis by 8-oxodG in α-synuclein aggregation and the pathogenesis of Parkinson's disease. Basu S; Je G; Kim YS Exp Mol Med; 2015 Aug; 47(8):e179. PubMed ID: 26315598 [TBL] [Abstract][Full Text] [Related]
20. Boosting chaperone-mediated autophagy in vivo mitigates α-synuclein-induced neurodegeneration. Xilouri M; Brekk OR; Landeck N; Pitychoutis PM; Papasilekas T; Papadopoulou-Daifoti Z; Kirik D; Stefanis L Brain; 2013 Jul; 136(Pt 7):2130-46. PubMed ID: 23757764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]